Bone applications reversible

Although the first demonstration that amino acid racemization took place in fossils used mollusc shells (23), the application of this reaction in dating these materials has been extensively investigated only recently (19,20). Work on Mercenaria (19), Chione (20), and other species (24) has tested the application of racemization dating to fossil mollusc shells from geological contexts and Indian shell middens. These and other studies have shown that there are problems with amino acid racemization dating of carbonaceous fossils which are not encountered with bone. Reversible first-order racemization kinetics which are observed in bone... 

The last method to be discussed, which is used to form polymer/ceramic composites by electrospinning, is extremely different to the methods previously described, but worth mentioning. Zuo et al. [129] used a method to create a composite scaffold that is actually the reverse of what most people are doing. Instead of mineralizing the nanofibers, Zuo et al. actually incorporated electrospun polymer nanofibers into a ceramic bone cement in order to form a composite scaffold. It was found that by incorporating electrospun nanofibers into the cement, the scaffold became less brittle and actually behaved similarly to that of a ductile material because of the fibers. Composite scaffolds with different polymers and fiber diameters were then tested in order to determine which scaffold demonstrated the most ideal mechanical properties. However, no cell studies were conducted and this method would most likely be used for a bone substitute instead of for bone regeneration applications. 

Genetic toxicity testing follows the reconmiended test battery as outlined in Option 1 of ICH S2(R1), employing two in vitro assays (bacterial reversion mutation and chromosomal aberrations in hPBLs, +/- S9 metabolic activation) and the in vivo rat bone marrow micronucleus assay. Intracellular exposure to the full-length parent drug product has been demonstrated in all three assay systems (thereby applicable across different sequences). 

A first application of the new, very efficient asymmetric synthesis of C2-sym-fnetric ketones is described in scheme 7. Since the Center for Disease Control in Atlanta (USA) defined the diagnostic term AIDS (Acquired Immunodeficiency Syndrome) in 1982 [24] only three medications have been authorized for treatment of AIDS 3 -azido-3 -deoxythymidine (AZT, Wellcome, 1987), 2 ,3 -dideoxyinosine (DDI, Bristol Myers Squibb, 1992), and 2 ,3 -dideoxycytosine (DDC, Hoffmann La Roche, 1992), which was recently introduced for limited use. These drugs inhibit the enzyme reverse transcriptase of the human immunodeficiency virus (HIV). Nevertheless, they are only able to prolong somewhat the survival of patients with advanced cases of AIDS. They also lead to considerable side-effects (bone marrow damage, neuropathy) and to the generation of more resistant strains of the virus [25]. 

Nine cases of bone marrow depression following the application of thiamphenicol have been observed in a hospital in France. In 5 of the patients the damage appeared to be reversible, but in 4 of them the neutropenia contributed to the fatal development of the infections (33 -). 

---